Are You on a Journey with Alpha-1 Liver Disease?

There is currently no approved treatment for Alpha-1 Liver Disease. The Redwood Study is testing whether an investigational drug called fazirsiran could help reduce liver scarring in adults living with this condition.

You May Prequalify

If a doctor has confirmed you have Alpha-1 Liver Disease, you may be able to take part. Consider completing a short questionnaire that can help determine if you may be a potential candidate for the study.

Age

18–75 years old

You may be eligible if you’re between 18 and 75 years old.

Condition

Alpha-1 Liver Disease

You have a confirmed diagnosis of Alpha-1 Liver Disease.

See if you prequalify

Steps for Joining

Prescreening helps you and the study team determine whether The Redwood Study is a good fit for you. This step-by-step process guides you from a short, 3-minute questionnaire through eligibility review, so you can decide whether participating feels right for you.

1

Answer a few questions

Complete a short, 3-minute questionnaire to see if you may be a fit for the study.

2

Speak with a study team member

If you appear to be a potential match, a research site you select will reach out within a few business days to give you more information about the study and confirm your eligibility.

3

You decide whether to join

If you meet all study requirements, the study doctor may invite you to take part in The Redwood Study. Choosing to join the study is up to you. Feel free to ask questions – you can take your time deciding what feels right.

Get Started

Take this 3-minute questionnaire with 7 short questions about your health. Your answers will help us determine your eligibility as a potential participant for the study. If you prequalify, we will ask for your contact information to share with a research site of your choosing. The study site will then contact you to talk about the study and next steps.

See If You May Prequalify

Step 1 of 3

Filling out this questionnaire does not mean you are obligated to participate in this clinical research study. At the end of the questionnaire, you have the opportunity to decide whether your answers are saved and can be submitted to a local research site for additional review regarding your eligibility for the study. If the site concludes that you would be a match, they may contact you to share additional information about the study and to schedule an appointment.

By answering the following questions, you agree that a research site representative may follow up by phone or email (as provided) regarding your interest in study participation only. If you are completing the questionnaire on behalf of someone else, please answer questions using their information.

Do you agree to submit your information?
Are you answering these questions for yourself?

e.g., 12345

MM/DD/YYYY

This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, read the privacy policy.

New clinical trials are always beginning. Would you be interested in future Takeda study opportunities? If so, please sign up at WeConnectPatients.com.